The University of Oklahoma is a public research university in Norman, Oklahoma. Founded in 1890, it had existed in Oklahoma Territory near Indian Territory for 17 years before the two became the state of Oklahoma. In Fall 2018 the university had 31,702 students enrolled, most at its main campus in Norman.

During the past decade, University of Oklahoma conducted 66 clinical trials. In the 10-year time frame, 66 clinical trials started and 43 clinical trials were completed, i.e. on average, 65.2% percent of trials that started reached the finish line to date. In the past 5 years, 23 clinical trials started and 17 clinical trials were completed. i.e. 73.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Oklahoma" #1 sponsor was "University of Oklahoma" with 11 trials, followed by "SCRI Development Innovations, LLC" with 7 trials sponsored, "Biosense Webster, Inc." with 5 trials sponsored, "National Cancer Institute (NCI)" with 5 trials sponsored and "Yale University" with 5 trials sponsored. Other sponsors include 131 different institutions and companies that sponsored additional 109 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Oklahoma" #1 collaborator was "University of Oklahoma" with 11 trials as a collaborator, "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 5 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 5 trials as a collaborator, "Penn State University" with 5 trials as a collaborator and "University of Pennsylvania" with 5 trials as a collaborator. Other collaborators include 144 different institutions and companies that were collaborators in the rest 113 trials.

According to Clinical.Site data, the most researched conditions in "University of Oklahoma" are "Breast Cancer" (6 trials), "Ovarian Cancer" (5 trials), "Cervical Cancer" (4 trials), "HIV Infections" (4 trials) and "Prostate Cancer" (4 trials). Many other conditions were trialed in "University of Oklahoma" in a lesser frequency.

Most popular intervention types in "University of Oklahoma" are "Drug" (88 trials), "Procedure" (28 trials), "Device" (26 trials), "Biological" (21 trials) and "Other" (18 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (10 trials), "Methotrexate" (4 trials), "Carboplatin" (3 trials), "Cyclophosphamide" (3 trials) and "Paclitaxel" (3 trials). Other intervention names were less common.

The vast majority of trials in "University of Oklahoma" are 130 trials for "All" genders, 34 trials for "Female" genders and 5 trials for "Male" genders.

Currently, there are NaN active trials in "University of Oklahoma". 1 are not yet recruiting, 28 are recruiting, 15 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 98 completed trials in University of Oklahoma, undefined suspended trials, and 19 terminated clinical trials to date.

Out of the total trials that were conducted in University of Oklahoma, 25 "Phase 1" clinical trials were conducted, 47 "Phase 2" clinical trials and 39 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 8 trials, and there were also 29 trials that are defined as “Not Applicable".